Zofran Birth Defect MDL Finally Heading For Trial In Fall

By Brian Dowling · February 24, 2021, 3:42 PM EST

A Massachusetts federal judge running the first bellwether in multidistrict litigation over whether GlaxoSmithKline's anti-nausea medication Zofran causes birth defects said Wednesday that he's considering an October starting date after a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015

Recent Articles By Brian

July 29, 2024
Ex-Pharma Exec Seeks Leniency After SEC Contempt Plea
July 12, 2024
Boston To Pay $1M To End Health Dept. Harassment Case
July 10, 2024
Drug Test Co. Pays $1M To Settle Medicare Fraud Claims
June 10, 2024
Medical-Aesthetic Device Rivals Set For Sept. Poaching Trial
May 29, 2024
Whistleblower Counsel Can't Get 'Exorbitant' $11.5M Fee
May 17, 2024
FCA Relators Seek Finders Fee For SpineFrontier Doc Deals
May 17, 2024
Mass. Hospital Pays $24.3M To Settle Heart-Surgery FCA Case
May 16, 2024
Ex-Pharma Exec Cops To Contempt For Barred Finance Work
April 22, 2024
Dentist Must Face Harassment Suit, Mass. Panel Says
March 28, 2024
Implant Maker's Bribe Case Ripe For Trimming, Judge Says